[
    [
        {
            "time": "2018-07-26",
            "original_text": "US Indexes Close Mostly Lower Thursday After GDP Report",
            "features": {
                "keywords": [
                    "Indexes",
                    "Close",
                    "Lower",
                    "GDP",
                    "Report"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "economy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "US Indexes Close Mostly Lower Thursday After GDP Report",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-08-01",
            "original_text": "Why Eli Lilly Stock Is Down Today",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock",
                    "Down",
                    "Today"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Why Eli Lilly Stock Is Down Today",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-08-01",
            "original_text": "Eli Lilly Stock Falls as Sales Disappoint. Analyst Welcomes Data on Diabetes Drug.",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock",
                    "Falls",
                    "Sales",
                    "Disappoint",
                    "Diabetes",
                    "Drug"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Stock Falls as Sales Disappoint. Analyst Welcomes Data on Diabetes Drug.",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "Lilly (LLY) Q2 Earnings Top Estimates, Sales Lag, Stock Down",
            "features": {
                "keywords": [
                    "Lilly",
                    "Q2",
                    "Earnings",
                    "Top",
                    "Estimates",
                    "Sales",
                    "Lag",
                    "Stock",
                    "Down"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly (LLY) Q2 Earnings Top Estimates, Sales Lag, Stock Down",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-07-29",
            "original_text": "Eli Lilly Misses Q2 Revenue Forecast, Lifts 2020 Profit Outlook",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Misses",
                    "Q2",
                    "Revenue",
                    "Forecast",
                    "Lifts",
                    "2020",
                    "Profit",
                    "Outlook"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Misses Q2 Revenue Forecast, Lifts 2020 Profit Outlook",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "Eli Lilly (LLY) Q2 Earnings Top Estimates",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Q2",
                    "Earnings",
                    "Top",
                    "Estimates"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Q2 Earnings Top Estimates",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "Recap: Eli Lilly Q2 Earnings",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Q2",
                    "Earnings"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Recap: Eli Lilly Q2 Earnings",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-01",
            "original_text": "Eli Lilly starts mid-stage study of COVID-19 treatment",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "mid-stage",
                    "study",
                    "COVID-19",
                    "treatment"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly starts mid-stage study of COVID-19 treatment",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-07-29",
            "original_text": "Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "stock",
                    "rallies",
                    "profit",
                    "beat",
                    "raised",
                    "outlook",
                    "revenue",
                    "fell",
                    "short"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "Eli Lilly's profit rises 6.4% on diabetes drug strength",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "profit",
                    "rises",
                    "diabetes",
                    "drug",
                    "strength"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly's profit rises 6.4% on diabetes drug strength",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-07-29",
            "original_text": "Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance",
            "features": {
                "keywords": [
                    "Lilly",
                    "Second-Quarter",
                    "Financial",
                    "Results",
                    "Raises",
                    "EPS",
                    "Guidance"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-01",
            "original_text": "Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes",
            "features": {
                "keywords": [
                    "Jardiance",
                    "primary",
                    "endpoint",
                    "reducing",
                    "risk",
                    "cardiovascular",
                    "death",
                    "hospitalization",
                    "heart",
                    "failure",
                    "phase",
                    "III",
                    "trial",
                    "adults",
                    "diabetes"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]